Speakers: Dr. Valencia Thomas, Dr. Kirk Sidey, Dr. Michal Kidacki, and Faith McNicholas
Sp26 Agenda.pdf
In support of improving patient care, this activity has been planned and implemented by the University of Iowa Roy J. and Lucille A. Carver College of Medicine and Iowa Dermatological Society The University of Iowa Roy J. and Lucille A. Carver College of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate: The University of Iowa Roy J. and Lucille A. Carver College of Medicine has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other Health Care Providers: A certificate of participation will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.)
Learning Objectives:
The Diagnosis and Management of Rare Tumors and Tumor Syndromes
- Identify rare tumor syndromes
- Develop a framework for the management of rare tumors and tumor syndromes
- Discuss longitudinal care for patients with rare tumors and tumor syndromes
2026 Coding and Updates in Dermatology
- Describe current annual payer policies and documentation requirements that support medical necessity for dermatologic services.
- Apply payer policies and documentation guidelines to dermatology services to promote accurate coding and minimize denials.
- Identify and select appropriate codes for common dermatologic procedures and diagnoses.
High-Risk Squamous Cell Carcinoma
- Utilize appropriate tools to predict clinical outcomes for cutaneous squamous cell carcinoma.
- Describe the utility of neoadjuvant and adjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma.
- Recognize when adjuvant radiation therapy should be considered for high-risk cutaneous squamous cell carcinoma.
Hidradenitis Suppurativa:
- Identify clinical indications and patient selection criteria for deroofing in the management of hidradenitis suppurativa.
- Describe the procedural steps of deroofing, including operative technique, peri-procedural management, and wound care.
- Discuss expected recovery timelines, wound healing, and typical outpatient logistics associated with deroofing procedures.
- Compare deroofing with alternative surgical approaches for hidradenitis suppurativa.
Getting There from Here: Surgical and Pathology Pearls
- Optimize techniques for special site biopsies.
- Utilize uncommon suture and closure techniques in difficult situations.
- Better understand and decipher cutting-edge pathology reports.
